Three in five liver cancer cases are due to preventable risk factors
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer c1
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer c1
Drs. Maria Carlota Londoño and Sabela Lens, hepatologists at Hospital Clínic and researchers in the Viral, Genetic and Immuno-mediated Liver Diseases1
Last May, Hospital Clínic Barcelona-IDIBAPS hosted the first face-to-face meeting of the European Network for Vascular Liver Diseases (EURO-VALDI-NET1
Researchers from Hospital Clínic Barcelona and IDIBAPS have participated in the development of the first European clinical guidelines dedicated exclu1
Hospital Clínic Barcelona has reached the milestone of 1,000 TIPS procedures performed, consolidating its position as an international reference cent1
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic, IDIBAPS, and the University of Barcelona, strengthens its internat1
The European Association for the Study of the Liver (EASL) has published an update of its guidelines for the management of hepatocellular carcinoma (1
A team of researchers from the Clínic-IDIBAPS have analysed the capacity of an artificial intelligence model to classify liver lesions after a magnet1
This is the first time that the members of the European reference network in rare liver diseases meet outside the headquarters, in Hamburg.
Researchers from Hospital Clínic-IDIBAPS and the CIBER Hepatic and Digestive Diseases (CIBEREHD) have led a European study to evaluate the efficacy o1